Navigation Links
Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego
Date:5/16/2013

SAN DIEGO, May 16, 2013 /PRNewswire/ -- The registration deadline has been extended until May 22 for the Association of Bioscience Financial Officers (ABFO) 2013 National Conference, the premier conference for bioscience financial officers. The conference will be held May 28-31 at the Hilton San Diego Bayfront.

"We are putting the finishing touches on this year's conference and want to make sure as many people as possible have the opportunity to attend," said Brandi Roberts , Chief Financial Officer of Mast Therapeutics, Inc. and the 2013 National Conference Chair.

More than 140 financial leaders from life sciences companies have already registered for the conference.  The theme for the 2013 National Conference is "Creating and Capturing Value in Bioscience." The conference includes keynote speakers and breakout sessions all with a focus on value beyond just the areas of finance and accounting, encompassing operational excellence, business development, regulatory expertise and team building.  

Through keynote addresses and breakout sessions, ABFO will welcome numerous speakers, including:

  • Michael Abrashoff , Former Navy Commander and Author
  • Brian Baker , VP of Finance, Cleave Biosciences
  • Robert Baltera , Former CEO, Amira Pharmaceuticals , Inc.
  • Daniel Bradbury , Former CEO, Amylin Pharmaceuticals, Inc.
  • David Conway , Sr. Director Clinical Operations, Halozyme Therapeutics
  • Brian Culley , CEO, Mast Therapeutics, Inc.
  • Karin Eastham , Board Member – MorphoSys AG, Trius Therapeutics, Illumina, Crosswalk Press LLC, Geron
  • Mark Foletta , Former CFO, Amylin Pharmaceuticals, Inc.
  • Alan Fuhrman ,Chief Financial Officer, Ambit
  • Koji Fukumura , Partner, Cooley LLP
  • Carol Gallagher , Former President and CEO of Calistoga Pharmaceuticals
  • Greg Guarasci , Sr. VP of Clinical Operations, PRA International
  • Hans-Peter Guler , Sr. VP Clinical Development, Endocrine & Cardiovascular, INC. Research
  • Faheem Hasnain , President and CEO, Receptos
  • Kent Hawryluk , CEO, Tall Ship Group, LLC
  • Robert Hoffman , Senior Vice President, Finance and CFO, Arena Pharmaceuticals
  • Gary A. Holden , Director of Information Technology, Vical Incorporated
  • Jason Kent , Partner, Cooley LLP
  • Moisha Platto , VP Proposals & Finance, PRA International
  • Dr. Stanley Rockson , Chief of Consultative Cardiology at Stanford University School of Medicine
  • Killu Sanborn , Oxford Finance
  • Tamara A. Seymour , CFO, HemaQuest Pharmaceuticals, Inc.
  • Armen B. Shanafelt , Ph.D., Venture Partner, Lilly Ventures
  • Larry Smith , FASB Member
  • Phil Schneider , Former CFO, IDEC Pharmaceuticals
  • Lisa Thompson , Associate Director of Lean Enterprise Center of Excellence, Hologic | Gen-Probe
  • Will Waddell , Sr. Vice President, Chief Financial Officer, OncoMed Pharmaceuticals, Inc.
  • Robert Williamson , Founder, LaSalle Venture Advisers, Former Director, Pharmasset
  • Troy Wilson , President and CEO, Wellspring Biosciences LLC
  • Jerry Wright , Senior Vice President of Lean and Enterprise Excellence, DJO Global

Registration can be completed online at www.abfointernational.org/conference through May 22, 2013.  The cost to attend the conference is $1,300, and up to 18 hours of continuing education credits are available.  For more information about the conference, contact Brandi Roberts at broberts@mastthera.com.

Sponsors of the event include AON, Bank of America Merrill Lynch, Brinson Patrick , Ernst & Young, Oxford Finance and Cooley LLP.  The conference is also supported by Russo Partners, PR Newswire and BioCentury.

About the Association of Bioscience Financial Officers

Formed in 1989, the Association of Bioscience Financial Officers has eleven chapters that serve as forums for the exchange of information about the industry and networking. Regional chapters are based in top bioscience concentrations to allow for face-to-face meetings and discussion of hot topics of interest to bioscience financial officers. The regional chapters meet annually for the ABFO National Conference for extended networking. For more information, visit www.abfointernational.org.

Media Contact: 
Ian Stone or Monica May 
Russo Partners 
(619) 308-6541  
(619) 308-6542 
ian.stone@russopartnersllc.com 
monica.may@russopartnersllc.com


'/>"/>
SOURCE Association of Bioscience Financial Officers
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Regado Biosciences, Inc. Files Registration Statement for Proposed Initial Public Offering
2. Registration Now Open for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego
3. Marrone Bio Innovations Submits New Bioherbicide for EPA Registration
4. Ambit Biosciences Files Registration Statement for Proposed Initial Public Offering
5. Bayer CropScience Announces Registration for use of Alion on Grapes in California
6. Regulus Files Registration Statement for Proposed Initial Public Offering
7. National Defense Industrial Association (NDIA) Opens Registration For 2012 Biosurveillance Conference, Set For August 27-28 in Washington, D.C.
8. Human Pheromone Sciences Voluntarily Files With SEC for Termination of Registration
9. Registration now open: 2012 Regional, State, and Local Initiatives in Nanotechnology
10. ETEX Corporation announces extended Supply Agreement with Knee Creations, LLC
11. 20% Off Your Entire Order of Scientific, Technical, Medical (STM) Book Titles Until the End of March at Chemical Publishing Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... ... a published evaluation of multiple immunoassay-based threat detection technologies by researchers from ... PathSensors’ CANARY® biosensor threat detection technology was found to have the best ...
(Date:2/23/2017)... , ... February 23, 2017 , ... The Greater ... a new partnership with Compass Research . GGI's mission is to advance global ... to a child in need in honor of each clinical trial volunteer. The vision ...
(Date:2/23/2017)... DIEGO and SAN FRANCISCO ... a privately-held regenerative medicine company, and Beyond Type 1, ... with type 1 diabetes, today announced a grant from ... a functional cure for type 1 and other insulin-requiring ... ViaCyte has been developing innovative stem cell-derived cell replacement ...
(Date:2/22/2017)... ... February 22, 2017 , ... Kernel , ... Research Systems, LLC (KRS) clinical development program. KRS is a neurotechnology spin-out ... research and clinical applications. The terms of the transaction were not disclosed. ...
Breaking Biology Technology:
(Date:2/10/2017)... 2017 Research and Markets has ... Medicine - Scientific and Commercial Aspects" to their offering. ... ... integrated with therapy for selection of treatment as well for ... prevention of disease in modern medicine. Biochip/microarray technologies and next ...
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... The global synthetic-biology ... $11.4 billion by 2021, growing at a compound annual growth ... An overview of the global markets for synthetic biology. - ... for 2016, and projections of compound annual growth rates (CAGRs) ...
(Date:2/7/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and ... present at the LEERINK Partners 6th Annual Global Healthcare ... Wednesday, February 15, 2017 at 10 a.m. Eastern Time. ... can be accessed at http://wsw.com/webcast/leerink28/zbh .  The webcast ... Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com . ...
Breaking Biology News(10 mins):